Background: Spinal muscular atrophy (SMA) causes progressive respiratory muscle weakness but respiratory function (RF) in those using noninvasive ventilation (NIV) is not well described.
| INTRODUCTION
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder associated with progressive muscle weakness and eventual respiratory failure, which may be difficult to detect early in life. SMA has several types, with type 1 being the most severe. Children with type 1 have respiratory failure in the first year. Children with type 2 and 3 have a variable course, but most children with type 2 eventually progress onto respiratory failure, either intermittently during lower respiratory tract infections (LRTI) or chronically, requiring nocturnal noninvasive ventilation (NIV). The clinical course in type 3 is generally milder, although some children require intermittent or long term nocturnal NIV.
For some neuromuscular diseases, such as Duchenne muscular dystrophy (DMD), there are clear guidelines for performance of sleep studies, instigation of NIV and home base physiotherapy support, but the level of evidence in SMA is poor. [1] [2] [3] [4] Spirometry has been the mainstay of respiratory assessment in SMA, but is volitional and young children may be unable to perform the test. Longitudinal changes in some respiratory function (RF) tests have previously been described 5 but the relationship between RF and polysomnography (PSG) findings has not been extensively researched in SMA, particularly in younger children, some by this study group. 6, 7 Need for respiratory assessment has become more relevant with the improved availability of NIV and newer disease-modifying medications such as Nusinersen.
The aims of the study are to describe RF in childhood Nusinersen naive SMA and assess differences in those using NIV for sleepdisordered breathing (SDB) or LRTI compared with those not requiring respiratory support. The authors hypothesize that children using NIV will have more abnormal RF than those not using NIV. 
| METHODS

| Polysomnography
Full diagnostic PSG was performed for all subjects by standard methods (see the Supporting Information). 8 Children requiring nocturnal NIV underwent NIV titration studies using a standard manual titration protocol to adjust the interface and ventilator settings and optimize breathing parameters and gas exchange.
Where feasible, children requiring NIV periodically have a diagnostic component during their PSG (split study) to assess for changes in underlying PSG findings. Where this had occurred, the diagnostic only component of the sleep study was collected separately; otherwise, the last full diagnostic PSG was used as baseline data.
SDB was defined as total apnea-hypopnea index (AHI) greater than 5/h. No child in this cohort required daytime NIV.
| Respiratory function tests
Multiple modalities were used to prospectively evaluate RF depending on age and cooperation of the child. Children who refused to perform a test were not forced. Respiratory function tests were reported as z-scores
where reference values exist, to allow for ready comparison across the pediatric age range. 9, 10 The RF tests were spirometry, forced oscillation technique (FOT), lung clearance index (LCI), sniff nasal inspiratory pressures, peak cough flow (PCF), and maximal inspiratory and expiratory pressure. Standard methods were used (see Supporting Information). [11] [12] [13] [14] [15] [16] All RF tests were performed a time distant to an LRTI.
| Statistical analysis
Stata version 11 was used to analyse the results. Baseline and clinical characteristics and feasibility of testing are described. An association between PSG and RF parameters was sought using regression analysis and multivariate analysis using stepwise regression. the Mann-Whitney U test was used to assess for differences in RF parameters for children requiring NIV and those not requiring NIV, and for those with SDB on PSG compared with those starting NIV during a chest infection. The odds ratio for needing NIV at various RF parameter cut-offs were explored.
Differences in PSG parameters during the diagnostic and NIV titration studies were assessed with the t test.
| RESULTS
| Baseline characteristics
Twenty-five children (median age (interquartile range [IQR]) 8.96 (5.63); 10 F) were included in the analysis with a median age (IQR) of 8.96 (5.63) years. Three children had SMA type 1, 15 had SMA type 2, and 7 had SMA type 3. The baseline characteristics are summarized in Table 1 . Ten children were using regular nocturnal NIV during the study period. The reason for starting NIV, age at initiation and duration of treatment before study inclusion are summarized in Table 2 .
| Feasibility
All children were able to undertake a full PSG. Not all children were able to perform the RF tests to the required standard. See Table 3 . In young children, understanding, concentrating, and cooperating with testing were the limiting factors. However, preschool spirometry and FOT was feasible in children as young as 3 years, and all respiratory tests could be performed by children over 8 years. In older children with more advanced disease, weakness of the muscles of the mouth and face became more problematic for generating a good mouth seal and mouth opening could be limited due to contractures, which impeded usage of a mouthpiece, including a snorkel.
| Respiratory function and PSG
The RF findings for type 1, 2, and 3 are summarized in Table 1 . The time between diagnostic sleep study and performing the suite of RF tests had a median of 0.07 months (IQR, 26.76 months). Univariate regression analysis for a relationship between the RF tests and total AHI, rapid eye movement (REM) AHI, and maximum transcutaneous carbon dioxide (TcCO 2 ) revealed the only significant relationships were for forced vital capacity (FVC) % predicted (P < .05) and FVC z-score (P < .04) to maximum TcCO 2 . The LCI relationship to maximum TcCO 2 was not significant (P = .17) for univariate analysis.
Two outliers had normal RF, but significant SDB, see Figure 1 .
Stepwise multivariate regression analysis showed that the combination of FVC z-score and LCI were more closely associated with maximum TcCO 2 on PSG (r = 0.43, P < .001) than either test alone.
| Noninvasive ventilation
Ten children were habitually using nocturnal NIV at the time of this study. Five began following a sleep study showing SDB, and 5 children were started during an LRTI that led to intensive care admission(s) for NIV. Three of these 5 children had contemporary PSG in the preceding 12 months that did not show significant SDB.
The age of initiation and durations of NIV are summarized in Table 2 .
Children with SMA requiring NIV were older (median, 10.52 vs 5.67 years; P < .02) with significantly more abnormal FVC z-score (−5.70 vs −1.39; P < .02), Rsr8 z-score (+1.97 vs +0.50, P = .04), and LCI (8.84 vs 7.34, P = .01) values than those not needing NIV, see In our center, children with SMA are prospectively monitored for SDB and hypoventilation by performance of annual (or more regular if required) full PSG. As a result, SDB is generally detected early, when the AHI greater than 5, sometimes with REM rises in CO 2 .
Children often do not fulfill the criteria for hypoventilation when SDB is first diagnosed and NIV is offered. As a result, only 2 children in this series met the criteria for hypoventilation. The level of peak in CO 2 levels, generally seen in REM sleep does offer some insight into the progression of early SDB, and the peak CO 2 was used in statistical analysis, rather than the percentage of time CO 2 greater than 50 mm Hg. Had the recent consensus statement been followed, many more of these children would have been offered NIV. 2 However, we believe that starting NIV for early SDB rather than hypoventilation is appropriate in the absence of better evidence to guide timing of NIV.
This study has included all children with SMA who reside in 6 In that study, the PSG were all contemporary, however, subject numbers were smaller (12 compared to 25). None of the included patients had advanced disease state, and all were aged less than 10 years. Five of the 12 were using NIV habitually. It is possible that the relationship between RF and PSG parameters change in advanced disease state, or it may be that the current study did not detect associations with PSG findings as well due to the delay between diagnostic PSG and the RF testing. 
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With the recent availability of Nusinersen in many countries, it will be important to assess the influence of Nusinersen on RF carefully in children with SMA. Forced vital capacity and LCI should be considered important RF parameters to include in these studies.
This study suggests that and FVC less than −2 z-scores or and LCI greater than 7 should have a PSG to assess for SDB and should be considered at higher risk of needing NIV during an LRTI. In the absence of SDB, children with RF in this range should be considered at risk of significant LRTI needing NIV. The ability to predict the need for NIV is important in resource allocation for both PSG and NIV equipment allocation, and will also be important in development for guidelines for respiratory care in SMA where directing resources to those at highest clinical risk is essential.
